Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscumin.
about
Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancerTriterpenoids amplify anti-tumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivoChallenges and future perspectives of T cell immunotherapy in cancerAdjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice
P2860
Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscumin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Tumor-associated CD75s ganglio ...... the anticancer drug rViscumin.
@en
type
label
Tumor-associated CD75s ganglio ...... the anticancer drug rViscumin.
@en
prefLabel
Tumor-associated CD75s ganglio ...... the anticancer drug rViscumin.
@en
P2093
P356
P1433
P1476
Tumor-associated CD75s ganglio ...... the anticancer drug rViscumin
@en
P2093
Bernhard Kniep
Iris Meisen
Jasna Peter-Katalinić
Johannes Müthing
Jörg Haier
Klaus Witthohn
Martin Langer
Norbert Senninger
Ulrich Neumann
P304
P356
10.1096/FJ.04-2494FJE
P407
P577
2004-11-01T00:00:00Z